Evidence map›Paper›PMID 31182584›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

Karen Dendoncker, Steven Timmermans, Jolien Vandewalle, Melanie Eggermont, Joanna Lempiäinen, Ville Paakinaho, Evelien Van Hamme, Sylviane Dewaele, Sofie Vandevyver, Marlies Ballegeer and 9 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. WTAP-mediated mScience China. Life sciences · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Observational
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 2 countries.

Karen DendonckerMouse Genetics in Inflammation, VIB Center for Inflammation Research, 9052 Ghent, Belgium.
Steven TimmermansMouse Genetics in Inflammation, VIB Center for Inflammation Research, 9052 Ghent, Belgium.
Jolien VandewalleMouse Genetics in Inflammation, VIB Center for Inflammation Research, 9052 Ghent, Belgium.
Melanie EggermontMouse Genetics in Inflammation, VIB Center for Inflammation Research, 9052 Ghent, Belgium.
Joanna LempiäinenInstitute of Biomedicine, University of Eastern Finland, 70211 Kuopio, Finland.
Ville PaakinahoInstitute of Biomedicine, University of Eastern Finland, 70211 Kuopio, Finland.
Evelien Van HammeDepartment of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium.
Sylviane DewaeleMouse Genetics in Inflammation, VIB Center for Inflammation Research, 9052 Ghent, Belgium.
Sofie VandevyverMouse Genetics in Inflammation, VIB Center for Inflammation Research, 9052 Ghent, Belgium.
Marlies BallegeerMouse Genetics in Inflammation, VIB Center for Inflammation Research, 9052 Ghent, Belgium.
Jolien SouffriauMouse Genetics in Inflammation, VIB Center for Inflammation Research, 9052 Ghent, Belgium.
Lise Van WyngeneMouse Genetics in Inflammation, VIB Center for Inflammation Research, 9052 Ghent, Belgium.
Kelly Van LooverenMouse Genetics in Inflammation, VIB Center for Inflammation Research, 9052 Ghent, Belgium.
Tineke VanderhaeghenMouse Genetics in Inflammation, VIB Center for Inflammation Research, 9052 Ghent, Belgium.
Rudi BeyaertMouse Genetics in Inflammation, VIB Center for Inflammation Research, 9052 Ghent, Belgium.ORCID 0000-0002-5704-582X
Karolien De BosscherMedical Biotechnology Center, VIB, 9000 Ghent, Belgium.ORCID 0000-0001-5059-9718
Jorma J PalvimoInstitute of Biomedicine, University of Eastern Finland, 70211 Kuopio, Finland.
Marc Van MontaguDepartment of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Ghent, Belgium; marc.vanmontagu@ugent.be claude.libert@irc.VIB-UGent.be.ORCID 0000-0003-4711-5131
Claude LibertMouse Genetics in Inflammation, VIB Center for Inflammation Research, 9052 Ghent, Belgium; marc.vanmontagu@ugent.be claude.libert@irc.VIB-UGent.be.
Ghent University · BEUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucocorticoid resistance (GCR) is defined as an unresponsiveness to the therapeutic effects, including the antiinflammatory ones of glucocorticoids (GCs) and their receptor, the glucocorticoid receptor (GR). It is a problem in the management of inflammatory diseases and can be congenital as well as acquired. The strong proinflammatory cytokine TNF-alpha (TNF) induces an acute form of GCR, not only in mice, but also in several cell lines: e.g., in the hepatoma cell line BWTG3, as evidenced by impaired Dexamethasone (Dex)-stimulated direct GR-dependent gene up- and down-regulation. We report that TNF has a significant and broad impact on this transcriptional performance of GR, but no impact on nuclear translocation, dimerization, or DNA binding capacity of GR. Proteome-wide proximity-mapping (BioID), however, revealed that the GR interactome was strongly modulated by TNF. One GR cofactor that interacted significantly less with the receptor under GCR conditions is p300. NFκB activation and p300 knockdown both reduced direct transcriptional output of GR whereas p300 overexpression and NFκB inhibition reverted TNF-induced GCR, which is in support of a cofactor reshuffle model. This hypothesis was supported by FRET studies. This mechanism of GCR opens avenues for therapeutic interventions in GCR diseases.

Indexed as

A549 CellsAnimalsCell NucleusDexamethasoneDown-RegulationDrug ResistanceE1A-Associated p300 ProteinFemaleGene Knockdown TechniquesGlucocorticoidsHEK293 CellsHumansInflammationMiceNF-kappa BProtein Interaction MappingDexamethasoneE1A-Associated p300 ProteinEP300 protein, humanEp300 protein, mouseGlucocorticoidsNF-kappa BNR3C1 protein, humanReceptors, GlucocorticoidRNA, Small InterferingTNF protein, humanTnf protein, mouseTumor Necrosis Factor-alphageneticsmechanismregulationtranscription

Identifiers

PMID31182584
PMCPMC6600915
OpenAlexW2953168058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.